381 related articles for article (PubMed ID: 25058855)
1. Use of animals for toxicology testing is necessary to ensure patient safety in pharmaceutical development.
Mangipudy R; Burkhardt J; Kadambi VJ
Regul Toxicol Pharmacol; 2014 Nov; 70(2):439-41. PubMed ID: 25058855
[TBL] [Abstract][Full Text] [Related]
2. Toxicology in the 21st century--working our way towards a visionary reality.
Berg N; De Wever B; Fuchs HW; Gaca M; Krul C; Roggen EL
Toxicol In Vitro; 2011 Jun; 25(4):874-81. PubMed ID: 21338664
[TBL] [Abstract][Full Text] [Related]
3. Alternative test methods in inhalation toxicology: challenges and opportunities.
Costa DL
Exp Toxicol Pathol; 2008 Jun; 60(2-3):105-9. PubMed ID: 18486462
[TBL] [Abstract][Full Text] [Related]
4. Current and Future Perspectives on the Development, Evaluation, and Application of in Silico Approaches for Predicting Toxicity.
Patlewicz G; Fitzpatrick JM
Chem Res Toxicol; 2016 Apr; 29(4):438-51. PubMed ID: 26686752
[TBL] [Abstract][Full Text] [Related]
5. Considerations regarding nonhuman primate use in safety assessment of biopharmaceuticals.
Buckley LA; Chapman K; Burns-Naas LA; Todd MD; Martin PL; Lansita JA
Int J Toxicol; 2011 Oct; 30(5):583-90. PubMed ID: 22013138
[TBL] [Abstract][Full Text] [Related]
6. In Vitro Developmental Toxicology Screens: A Report on the Progress of the Methodology and Future Applications.
Zhang C; Ball J; Panzica-Kelly J; Augustine-Rauch K
Chem Res Toxicol; 2016 Apr; 29(4):534-44. PubMed ID: 26766213
[TBL] [Abstract][Full Text] [Related]
7. Developing alternatives to systemic toxicity testing approaches.
von Aulock S
ALTEX; 2012; 29(1):1. PubMed ID: 22408846
[No Abstract] [Full Text] [Related]
8. Implementation challenges for designing integrated in vitro testing strategies (ITS) aiming at reducing and replacing animal experimentation.
De Wever B; Fuchs HW; Gaca M; Krul C; Mikulowski S; Poth A; Roggen EL; Vilà MR
Toxicol In Vitro; 2012 Apr; 26(3):526-34. PubMed ID: 22269383
[TBL] [Abstract][Full Text] [Related]
9. Aligning the 3Rs with new paradigms in the safety assessment of chemicals.
Burden N; Mahony C; Müller BP; Terry C; Westmoreland C; Kimber I
Toxicology; 2015 Apr; 330():62-6. PubMed ID: 25932488
[TBL] [Abstract][Full Text] [Related]
10. Development of alternative methods.
Goldberg AM
J Toxicol Sci; 1995 Sep; 20(4):443-9. PubMed ID: 8531238
[TBL] [Abstract][Full Text] [Related]
11. The fish embryo toxicity test as an animal alternative method in hazard and risk assessment and scientific research.
Embry MR; Belanger SE; Braunbeck TA; Galay-Burgos M; Halder M; Hinton DE; Léonard MA; Lillicrap A; Norberg-King T; Whale G
Aquat Toxicol; 2010 Apr; 97(2):79-87. PubMed ID: 20061034
[TBL] [Abstract][Full Text] [Related]
12. SEURAT: Safety Evaluation Ultimately Replacing Animal Testing--recommendations for future research in the field of predictive toxicology.
Daston G; Knight DJ; Schwarz M; Gocht T; Thomas RS; Mahony C; Whelan M
Arch Toxicol; 2015 Jan; 89(1):15-23. PubMed ID: 25433540
[TBL] [Abstract][Full Text] [Related]
13. The integrated project ReProTect: a novel approach in reproductive toxicity hazard assessment.
Hareng L; Pellizzer C; Bremer S; Schwarz M; Hartung T
Reprod Toxicol; 2005; 20(3):441-52. PubMed ID: 15899576
[TBL] [Abstract][Full Text] [Related]
14. Working in partnership to advance the 3Rs in toxicity testing.
Holmes AM; Creton S; Chapman K
Toxicology; 2010 Jan; 267(1-3):14-9. PubMed ID: 19903508
[TBL] [Abstract][Full Text] [Related]
15. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
[TBL] [Abstract][Full Text] [Related]
16. Pharmaceutical toxicology: designing studies to reduce animal use, while maximizing human translation.
Chapman KL; Holzgrefe H; Black LE; Brown M; Chellman G; Copeman C; Couch J; Creton S; Gehen S; Hoberman A; Kinter LB; Madden S; Mattis C; Stemple HA; Wilson S
Regul Toxicol Pharmacol; 2013 Jun; 66(1):88-103. PubMed ID: 23524271
[TBL] [Abstract][Full Text] [Related]
17. Predictive toxicology today: the transition from biological knowledge to practicable models.
Benigni R
Expert Opin Drug Metab Toxicol; 2016 Sep; 12(9):989-92. PubMed ID: 27351633
[No Abstract] [Full Text] [Related]
18. A roadmap for the development of alternative (non-animal) methods for systemic toxicity testing.
Basketter DA; Clewell H; Kimber I; Rossi A; Blaauboer B; Burrier R; Daneshian M; Eskes C; Goldberg A; Hasiwa N; Hoffmann S; Jaworska J; Knudsen TB; Landsiedel R; Leist M; Locke P; Maxwell G; McKim J; McVey EA; Ouédraogo G; Patlewicz G; Pelkonen O; Roggen E; Rovida C; Ruhdel I; Schwarz M; Schepky A; Schoeters G; Skinner N; Trentz K; Turner M; Vanparys P; Yager J; Zurlo J; Hartung T
ALTEX; 2012; 29(1):3-91. PubMed ID: 22307314
[TBL] [Abstract][Full Text] [Related]
19. How omics technologies can contribute to the '3R' principles by introducing new strategies in animal testing.
Kroeger M
Trends Biotechnol; 2006 Aug; 24(8):343-6. PubMed ID: 16782220
[TBL] [Abstract][Full Text] [Related]
20. The virtue of translational PKPD modeling in drug discovery: selecting the right clinical candidate while sparing animal lives.
Bueters T; Ploeger BA; Visser SA
Drug Discov Today; 2013 Sep; 18(17-18):853-62. PubMed ID: 23665277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
